Medtronic loses appeal of patent infringement case - Bring Me The News

Medtronic loses appeal of patent infringement case

Medtronic says it is evaluating its next step after a court rejected the company's appeal of a $74 million patent infringement ruling. The ruling could eventually force Medtronic to stop making one of its heart valves if a competitor - Edwards Lifesciences - seeks an injunction.
Author:
Publish date:

Medical device maker Medtronic was unsuccessful in its effort to overturn a $74 million jury verdict in a patent infringement case. The appeals court ruling also gives Edwards Lifesciences the right to seek an injunction blocking Medtronic from making some of its CoreValve heart valves.

The product replaces damaged aortic valves without open heart surgery. Medtronic's product is still awaiting approval from the FDA, but is on the market in Europe and has been implanted in sixty countries.

Next Up

Related

Medical alert issued for Medtronic's Entrust defibrillators

British regulators warn the device has a battery defect that can fail to properly shock a heart back into a normal rhythm. Patients are encouraged to see their cardiologists to ensure an audible "low-battery" alert is working properly. Fridley-based Medtronic denied any wrong doing, but settled lawsuits regarding battery issues in its Marquis line of defibrillators less than four years ago.

Medtronic cutting 220 jobs in Mounds View

Medtronic is eliminating jobs at the Mounds View facility that makes heart rhythm devices. Sales of the company's pacemakers and implantable defibrillators have been sluggish for years.